Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

E Douglas Williams

Affiliations

  • Director at Ovid Therapeutics Inc. (OVID), 2019-11-15
  • Director at Ironwood Pharmaceuticals Inc (IRWD), 2019-04-03
  • Director at Regulus Therapeutics Inc. (RGLS), 2016-06-03
  • Evp Research & Development at Biogen Inc. (BIIB), 2015-06-22
  • Director at Oncothyreon Inc. (ONTY), 2013-06-14
  • Director at Array Biopharma Inc (ARRY), 2010-11-08
  • Chief Executive Officer at Zymogenetics Inc (ZGEN), 2010-10-12
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
OVID $6.49 5,000 Director 5,000 2018-08-14 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BIIB $410.00 3,841 Officer 11,817 2015-06-19 Filing
BIIB $352.29 994 Officer 7,976 2014-03-19 Filing
BIIB $352.29 916 Officer 8,970 2014-03-19 Filing
BIIB $352.29 1,595 Officer 9,886 2014-03-19 Filing
BIIB $211.35 4,368 Officer 4,571 2013-08-26 Filing